• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU
Click for more information
4.80% $14.19

NEUREN PHARMACEUTICALS LIMITED

Market Cap $1.813B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NEU
Neuren Media and Analyst Coverage
21 22 23
21/09/24 1.3K 713K
21/09/24 Last post  seanc Comments Created with Sketch.  1.3K  Views Created with Sketch.  713K 
NEU
NEU chart
30 31 32
21/09/24 1.9K 1.0M
21/09/24 Last post  Trader Paul Comments Created with Sketch.  1.9K  Views Created with Sketch.  1.0M 
NEU
Share Price
198 199 200
21/09/24 11K 5.5M
21/09/24 Last post  kens Comments Created with Sketch.  11K  Views Created with Sketch.  5.5M 
NEU
Rare paediatric disease priority review 		21/09/24 31 21K
21/09/24 Last post  Innameonly Comments Created with Sketch.  31  Views Created with Sketch.  21K 
NEU
Acadia
13 14 15
20/09/24 847 400K
20/09/24 Last post  Brett ebony Comments Created with Sketch.  847  Views Created with Sketch.  400K 
NEU
What has changed? 		16/09/24 33 19K
16/09/24 Last post  What A Gas Comments Created with Sketch.  33  Views Created with Sketch.  19K 
NEU
Dr Nancy Jones 		10/09/24 0 719
10/09/24 Last post  kens Comments Created with Sketch.  0  Views Created with Sketch.  719 
NEU
Pitt Hopkins Phase 2 NNZ2591 results 		05/09/24 5 4.5K
05/09/24 Last post  Kryptonite Comments Created with Sketch.  5  Views Created with Sketch.  4.5K 

See All Discussions arrow Created with Sketch.

Timeline

H1 2024 financial results
27 Aug 09:17
 
Half Yearly Report and Accounts
27 Aug 09:12
 
Investor roadshow presentation, 19 August 2024
19 Aug 09:33
 
Change of Director's Interest Notice - J Basile
16 Aug 16:49
 
NNZ-2591 Angelman top-line results presentation
09 Aug 10:43
 
Phase 2 trial shows significant improvements in Angelman
09 Aug 10:01
 
View More arrow Created with Sketch.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.

(20min delay)
Last
$14.19 		Change
0.650(4.80%) 		Mkt cap ! $1.813B
Open High Low Value Volume
$13.65 $15.24 $13.63 $19.05M 1.328M

Buyers (Bids)

No. Vol. Price($)
4 5645 $14.18
 

Sellers (Offers)

Price($) Vol. No.
$14.20 172 1
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
$14.19 		  Change
0.650 ( 5.01 %)
Open High Low Volume
$13.69 $15.24 $13.69 134300
Last updated 16.10pm 20/09/2024 ?
NEU (ASX) Chart

Top Stories

Drilling shows continuous Cu mineralisation at Whundo for Greentech

Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025 Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Catalina Resources kicks off aircore drilling at Laverton project on the hunt for gold, REEs Catalina Resources has confirmed its latest drill run has kicked off on-site its Laverton Project in Western Australia's Northern Goldfields.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.